Search Results 311-320 of 16309 for pharmacogenetics
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...
Latest stories · Mayo Clinic uses genomic testing broadly for rare diseases, improves patient care featured image · How preeclampsia accelerates aging in women ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
The purpose of this study is to examine how well ascorbic acid and combination chemotherapy work in treating patients with lymphoma that has come back or ...
The purpose of this study is to test the effectiveness of an online education course for helping obese patients to reach and keep weight loss goals.
About this study. To determine utilization patterns of narcotic pain medication postoperatively for patients recovering from a general surgery or ...
The purpose of this study is to assess the effectiveness and safety of Lubiprostone in pediatric patients, aged ≥ 6 years to < 18 years, diagnosed with ...
Copland, our lab strives to create personalized cancer models and develop molecular-targeted therapies, focusing on renal cancer, thyroid cancer, liver cancer ...
Research curriculum for the PGY-2 Pharmacy Residency in Emergency Medicine at Mayo Clinic Hospital — Rochester (Minnesota).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.